| 摘要 |
Compounds of formula 1 are disclosed, wherein G, D, A, Q, Y, Z, and R 1 through R10 are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
|
